These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9916314)
41. Validation of a HPLC method for the determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes. Elbarbry F; Wilby K; Alcorn J J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):199-203. PubMed ID: 16497568 [TBL] [Abstract][Full Text] [Related]
42. Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-microm porous microspherical silica-gel. Tanaka E J Pharm Biomed Anal; 1998 Jan; 16(5):899-904. PubMed ID: 9535202 [No Abstract] [Full Text] [Related]
43. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies. Yamamura Y; Koyama N; Umehara K Xenobiotica; 2015 Apr; 45(4):353-60. PubMed ID: 25815637 [TBL] [Abstract][Full Text] [Related]
44. Estimation of the analgesic muscle relaxants chlorzoxazone and diazepam in human plasma by reversed-phase liquid chromatography. Gaitonde CD; Pathak PV J Chromatogr; 1990 Jun; 528(2):407-14. PubMed ID: 2384578 [TBL] [Abstract][Full Text] [Related]
45. Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2E1 Enzyme Activity: Inhibitory Effect of Cytochrome P450 Enzyme CYP2E1 by Salicylic Acid in Rat Liver Microsomes. Salhab H; Naughton DP; Barker J Molecules; 2020 Feb; 25(4):. PubMed ID: 32093091 [TBL] [Abstract][Full Text] [Related]
46. Differences in chlorzoxazone metabolism in full mature male and female Sprague-Dawley rat, Beagle dog and Cynomolgus monkey liver. Tanaka E; Shimamoto A; Nakamura T; Terao K; Misawa S Hum Exp Toxicol; 2000 Feb; 19(2):122-5. PubMed ID: 10773842 [No Abstract] [Full Text] [Related]
47. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119 [TBL] [Abstract][Full Text] [Related]
48. Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1. Lucas D; Menez JF; Berthou F Methods Enzymol; 1996; 272():115-23. PubMed ID: 8791768 [No Abstract] [Full Text] [Related]
49. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats. Chen L; Yang CS Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187 [TBL] [Abstract][Full Text] [Related]
50. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene. Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514 [TBL] [Abstract][Full Text] [Related]
51. Human hepatic alcohol dehydrogenase and human erythrocyte catalase do not metabolize the cytochrome P-4502E1 substrate, chlorzoxazone. McCarver-May DG; Durisin L Alcohol Clin Exp Res; 1996 May; 20(3):533-7. PubMed ID: 8727250 [TBL] [Abstract][Full Text] [Related]
52. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Benowitz NL; Peng M; Jacob P Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387 [TBL] [Abstract][Full Text] [Related]
53. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h. Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164 [TBL] [Abstract][Full Text] [Related]
54. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off. Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086 [TBL] [Abstract][Full Text] [Related]
55. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643 [TBL] [Abstract][Full Text] [Related]
56. [Changes of CYP2E1 activity in diabetic rat model]. Li L; Zhang Y Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852 [TBL] [Abstract][Full Text] [Related]
57. A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits. Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Aoki T; Kobayashi S Acta Anaesthesiol Scand; 1998 Oct; 42(9):1028-32. PubMed ID: 9809083 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model. Tortorici MA; Kochanek PM; Bies RR; Poloyac SM Crit Care Med; 2006 Mar; 34(3):785-91. PubMed ID: 16521272 [TBL] [Abstract][Full Text] [Related]
59. Development and validation of a simple LC method for the determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in rat microsomal medium. Zhai X; Lu Y Pharmazie; 2013 Jan; 68(1):19-26. PubMed ID: 23444776 [TBL] [Abstract][Full Text] [Related]
60. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment. Lee AM; Yue J; Tyndale RF Drug Metab Dispos; 2006 Sep; 34(9):1508-15. PubMed ID: 16763012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]